BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 1355362)

  • 1. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart].
    Böhm M; Schwinger RH; Erdmann E
    Z Kardiol; 1992; 81 Suppl 4():23-31. PubMed ID: 1337808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-adrenergic receptors of the normal heart and in heart failure].
    Krasnikov TL; Gabrusenko SA
    Usp Fiziol Nauk; 2000; 31(2):35-50. PubMed ID: 10822833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine selectively attenuates H2- and beta-mediated cardiac responses to histamine and norepinephrine: an unmasking of H1- and alpha-mediated responses.
    Hattori Y; Levi R
    J Pharmacol Exp Ther; 1984 Nov; 231(2):215-23. PubMed ID: 6092608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart.
    Pepe S; van den Brink OW; Lakatta EG; Xiao RP
    Cardiovasc Res; 2004 Aug; 63(3):414-22. PubMed ID: 15276466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor systems in the non-failing human heart.
    Brodde OE; Broede A; Daul A; Kunde K; Michel MC
    Basic Res Cardiol; 1992; 87 Suppl 1():1-14. PubMed ID: 1353955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure.
    Böhm M
    Thorac Cardiovasc Surg; 1998 Sep; 46 Suppl 2():270-5; discussion 276. PubMed ID: 9822178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S; Hattori Y; Akaishi Y; Nishihira J; Kanno M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-adrenergic receptor. Configuration, regulation, mechanism of action.
    Bristow MR
    Postgrad Med; 1988 Feb; Spec No():19-26. PubMed ID: 2894659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
    Katori T; Hoover DB; Ardell JL; Helm RH; Belardi DF; Tocchetti CG; Forfia PR; Kass DA; Paolocci N
    Circ Res; 2005 Feb; 96(2):234-43. PubMed ID: 15591228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.